Table 1.
Sample | Formation in mice | Latency to palpable tumor formation | Passage in Mice | Metastasis | Metastatic Latency | Age | Diagnosis | Grade | ER/PR/Her2 Status |
---|---|---|---|---|---|---|---|---|---|
4 | 0/2 | N/A | N/A | Not Determined | N/A | 56 years | IDC | Grade 2 | ER+/PR+/Her2- |
5 | 5/6 | 74 days | Yes | Yes | 254 days | 44 years | IDC | Grade 3 | ER+/PR+/Her2- |
6 | 6/6 | 47 days | Yes | Yes | 232 days | 62 years | IDC with lymphovascular invasion | Grade 2 | ER+/PR+/Her2+ |
7 | 5/6 | 72 days | Yes | Yes | 214 days | 77 years | IDC | Grade 2 | ER-/PR-/Her2- |
8 | 4/6 | 35 days | Yes | Yes | 248 days | 63 years | IDC | Grade 2 | ER+/PR+/Her2- |
9 | 6/6 | 46 days | Yes | Yes | 279 days | 66 years | IDC | Grade 1 | ER+/PR+/Her2 |
Tumor formation in NUDE mice following bilateral injections into the mammary fat pad of tumorspheres that were derived from the original patient biopsy. The latency or palpable tumor formation is indicated in number of days post-injection of tumorspheres into the mammary fat pad. 'Passage in mice' indicates that the primary tumor could be serially transplanted into mice to form subsequent primary tumors following in vitro formation of tumorspheres prior to injection into the mammary fat pad. Metastasis was determined by detection of human chromosome 17 by PCR using DNA isolated from mouse organs collected from mice injected with tumorspheres into the mammary fat pad. Metastatic latency is the average number of days between the injection of tumorspheres into the mammary fat pad and the detection of metastatic lesions in all organs analyzed by H+E staining